Poolbeg Pharma (STU:7JN) Capital Expenditure : €-0.15 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Poolbeg Pharma's cash flow for capital expenditures for the six months ended in Dec. 2024 was €-0.04 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.15 Mil.

Poolbeg Pharma Capital Expenditure Historical Data

The historical data trend for Poolbeg Pharma's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Capital Expenditure Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Capital Expenditure

-0.10

-0.69

-0.20

-0.16

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial			-0.24	-0.07	-0.13	-0.11	-0.04

Poolbeg Pharma Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.15 Mil.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (STU:7JN) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

POLBF:USA POLB:UK

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines